Cargando…
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which only symptomatic medication is available, except for the recently FDA-approved aducanumab. This lack of effective treatment urges us to investigate alternative paths that might contribute to disease development. In light...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385395/ https://www.ncbi.nlm.nih.gov/pubmed/35987492 http://dx.doi.org/10.1016/j.drudis.2022.103340 |